Results 131 to 140 of about 180,408 (257)

Proteomics Reveals Increased Periostin in Synovial Fluid From Canine and Human Anterior Cruciate Ligament Injury

open access: yesJournal of Orthopaedic Research, EarlyView.
ABSTRACT Posttraumatic osteoarthritis (PTOA) is a common sequela to anterior cruciate ligament (ACL) injury in humans and dogs. Identification of conserved targets between species may hasten biomarker identification and therapeutic development. To identify differentially regulated synovial fluid (SF) proteins in ACL injury, SF samples were collected ...
Sydney J. Womack   +4 more
wiley   +1 more source

Metabolic syndrome, plasminogen activator inhibitor (pai-1) and atherosclerosis

open access: yesZdravniški Vestnik, 2005
Background: Metabolic syndrome is associated with high cardiovascular morbidity and mortality and its increasing prevalence is becoming one of the major health problems.
Alenka Mavri
doaj  

Angioedema following venipuncture in a patient on angiotensin‐converting enzyme inhibitor and dipeptidyl peptidase‐IV inhibitor therapy: A case report

open access: yesJEADV Clinical Practice, EarlyView.
Abstract Acquired angioedema (AAE) is a rare, potentially life‐threatening condition, primarily induced by medications, with attacks typically triggered by major trauma. We report a rare case of AAE triggered locally by minor trauma—a forearm venipuncture—in a 77‐year‐old male taking ramipril and sitagliptin.
Adrien Bénic   +4 more
wiley   +1 more source

Viral load at hospitalization is an independent predictor of severe COVID‐19

open access: yes, 2023
European Journal of Clinical Investigation, Volume 53, Issue 1, January 2023.
Hjalmar Waller   +12 more
wiley   +1 more source

Data in support of a central role of plasminogen activator inhibitor-2 polymorphism in recurrent cardiovascular disease risk in the setting of high HDL cholesterol and C-reactive protein using Bayesian network modeling

open access: yesData in Brief, 2016
Data is presented that was utilized as the basis for Bayesian network modeling of influence pathways focusing on the central role of a polymorphism of plasminogen activator inhibitor-2 (PAI-2) on recurrent cardiovascular disease risk in patients with ...
James P. Corsetti   +5 more
doaj  

Enhancing Hemocompatibility in ECMO Systems With a Fibrinolytic Interactive Coating: in Vitro Evaluation of Blood Clot Lysis Using a 3D Microfluidic Model

open access: yesMacromolecular Bioscience, EarlyView.
The functionalization of antifouling polymer brushes with tissue plasminogen activator resulted in a coating system that can direct blood components to digest blood clots in medical devices. This study further demonstrates the ability of this coating system to enhance clot‐lysis in fluid dynamic conditions that are close to the ones in extracorporeal ...
Lena Witzdam   +7 more
wiley   +1 more source

The Roles of Fibrinolytic Factors in Bone Destruction Caused by Inflammation

open access: yesCells
Chronic inflammatory diseases, such as rheumatoid arthritis, spondyloarthritis, systemic lupus erythematosus, Crohn’s disease, periodontitis, and carcinoma metastasis frequently result in bone destruction.
Yosuke Kanno
doaj   +1 more source

Home - About - Disclaimer - Privacy